The
Report Pneumocystis Infection - Pipeline Review, H1 2016 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
Global
Markets Directs, Pneumocystis
Infection - Pipeline Review, H1 2016,
provides an overview of the Pneumocystis Infection pipeline
landscape.
The
report provides comprehensive information on the therapeutics under
development for Pneumocystis Infection, complete with analysis by
stage of development, drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Pneumocystis Infection and features
dormant and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download Sample copy of this
Report at : http://www.marketresearchreports.biz/sample/sample/726768
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Pneumocystis Infection
-
The report reviews pipeline therapeutics for Pneumocystis Infection
by companies and universities/research institutes based on
information derived from company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Pneumocystis Infection
therapeutics and enlists all their major and minor projects
-
The report assesses Pneumocystis Infection therapeutics based on drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Pneumocystis Infection
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Pneumocystis Infection
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Pneumocystis Infection pipeline depth and focus of Indication
therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Table of Contents
1 Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report
Coverage 5
Pneumocystis Infection Overview
6
Therapeutics Development 7
Pipeline Products for
Pneumocystis Infection - Overview 7
Pipeline Products for
Pneumocystis Infection - Comparative Analysis 8
Pneumocystis Infection -
Therapeutics under Development by Companies 9
Pneumocystis Infection -
Therapeutics under Investigation by Universities/Institutes 10
Pneumocystis Infection -
Pipeline Products Glance 11
Early Stage Products 11
Pneumocystis Infection -
Products under Development by Companies 12
Pneumocystis Infection -
Products under Investigation by Universities/Institutes 13
Pneumocystis Infection -
Companies Involved in Therapeutics Development 14
BioDiem Ltd 14
Matinas BioPharma Holdings,
Inc. 15
Pneumocystis Infection -
Therapeutics Assessment 16
Assessment by Monotherapy
Products 16
Assessment by Route of
Administration 17
Assessment by Molecule Type 18
Drug Profiles 19
atovaquone - Drug Profile 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
BDM-I - Drug Profile 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Pneumocystis pneumonia vaccine
- Drug Profile 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
pneumocystis vaccine - Drug
Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment